HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chih-Hsiang Leng Selected Research

Chih-Hsiang Leng Research Topics

Disease

17Neoplasms (Cancer)
01/2019 - 11/2009
8Dengue (Dengue Fever)
01/2016 - 02/2009
3Communicable Diseases (Infectious Diseases)
01/2019 - 08/2010
3Viremia
02/2016 - 03/2014
3Infections
01/2016 - 07/2007
3Virus Diseases (Viral Diseases)
01/2015 - 02/2009
3Human Influenza (Influenza)
08/2010 - 05/2009
3Severe Acute Respiratory Syndrome
07/2007 - 04/2006
2Inflammation (Inflammations)
08/2015 - 01/2015
2Diarrhea
08/2015 - 01/2015
2Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2014 - 01/2014
1Atherosclerotic Plaque (Atheroma)
01/2020
1Cross Infection (Nosocomial Infection)
08/2015
1Clostridium Infections
08/2015
1Colitis
01/2015
1Opportunistic Infections (Opportunistic Infection)
01/2015
1Meningococcal Meningitis
11/2010

Drug/Important Bio-Agent (IBA)

12AntigensIBA
01/2019 - 08/2010
10VaccinesIBA
01/2019 - 05/2009
7Peptides (Polypeptides)IBA
03/2015 - 07/2007
5Proteins (Proteins, Gene)FDA Link
11/2016 - 04/2006
4Lipoproteins (Lipoprotein)IBA
10/2016 - 03/2014
4Toll-Like Receptor 2IBA
05/2016 - 03/2014
4Neutralizing AntibodiesIBA
02/2016 - 07/2013
4Subunit VaccinesIBA
01/2015 - 01/2011
3Combined VaccinesIBA
01/2016 - 02/2009
3LipidsIBA
01/2015 - 03/2014
2Oncogene Proteins (Oncogene Protein)IBA
01/2018 - 01/2012
2Neoplasm Antigens (Tumor Antigens)IBA
01/2018 - 11/2016
2Recombinant ProteinsIBA
04/2016 - 01/2015
2aluminum sulfate (alum)IBA
02/2016 - 02/2014
2Dengue VaccinesIBA
01/2016 - 02/2009
2Anti-Bacterial Agents (Antibiotics)IBA
08/2015 - 01/2015
2trimethylaminocarboxyldihydroboran (TCDB)IBA
08/2015 - 01/2015
2Glycoproteins (Glycoprotein)IBA
08/2015 - 01/2015
2OligodeoxyribonucleotidesIBA
03/2014 - 01/2014
2LipopeptidesIBA
01/2014 - 08/2011
1Streptozocin (Streptozotocin)FDA Link
01/2020
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2020
1E-SelectinIBA
01/2020
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2020
1SurvivinIBA
01/2018
1Liposomes (Liposome)IBA
10/2016
11,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA
10/2016
1FlagellinIBA
04/2016
1GemcitabineFDA Link
03/2016
1Pharmaceutical PreparationsIBA
03/2016
1Programmed Cell Death 1 ReceptorIBA
03/2016
1ExotoxinsIBA
08/2015
1Papillomavirus Vaccines (HPV Vaccines)IBA
03/2015
1EndotoxinsIBA
01/2015
1CPG-oligonucleotideIBA
03/2014
1Toll-Like Receptor 9IBA
03/2014
1Toll-Like Receptor AgonistsIBA
03/2014
1Ethylene Glycol (Monoethylene Glycol)IBA
02/2014
1poly(lactide) (polylactic acid)IBA
02/2014
1squalaneIBA
02/2014
1EmulsionsIBA
01/2014
1EpitopesIBA
01/2014
1Protein Subunit VaccinesIBA
01/2014
1aluminum phosphateIBA
07/2013
1HLA-A11 AntigenIBA
11/2009
1Hemagglutinins (Hemagglutinin)IBA
05/2009
1Protein SIBA
07/2007
1Synthetic Vaccines (Recombinant Vaccines)IBA
07/2007
1Amino AcidsFDA Link
07/2007
1HLA-A*02:01 antigenIBA
05/2006
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
05/2006
1Urea (Carbamide)FDA LinkGeneric
04/2006

Therapy/Procedure

9Immunotherapy
01/2019 - 01/2014
4Therapeutics
05/2016 - 03/2014
1Treatment Delay
10/2016
1Drug Therapy (Chemotherapy)
03/2016